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Abstract
DEVELOPMENT AND COMMISSIONING OF AN INDEPENDENT PEER REVIEW
SYSTEM FOR A SMALL ANIMAL IRRADIATOR

Mary Elizabeth Peters, B.S.
Advisory Professor: Rebecca M Howell, Ph.D.

Dosimetry for small animal irradiators lacks the standardization of clinical
radiotherapy practice, yet plays a central translational role in human trial design. The
purpose of this work was to improve the dosimetric accuracy and consistency of
animal studies by developing an independent peer review system to verify dose
delivery from animal irradiators. This study focused on the development of a mouse
phantom and characterization of the thermoluminescent dosimetry system for a
commonly used small animal irradiator.
First, a mouse model and irradiation stand were designed with the purpose of
being used in a mailable audit. Two mouse phantoms were machined from high
impact polystyrene; one accommodated three thermoluminescent dosimeters (TLD)
and the other an Exradin A1SL 0.053 cc ion chamber (Standard Imaging, Middleton,
WI) for cross-comparison with the TLD. An acrylic irradiation stand was constructed
to allow users to align the mouse phantom to the irradiator’s isocenter. Second, the
mouse system was commissioned in a small animal irradiator using a 225 kVp
beam. A pseudo tissue-air ratio was determined using the ion chamber mouse
phantom. The dose rate was determined using the TG-61 “in-air” method, along
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with the measured half-value layer of the beam. The response of the TLD in the
mouse phantom was characterized under identical irradiation conditions. Lastly, the
commissioned mouse system was mailed to two institutions to verify feasibility of the
service.
We designed a robust, user-friendly mouse phantom and foldable irradiation
stand, ideal for a mail audit service. The system was commissioned at 225 kVp in a
small animal irradiator. The energy correction factor for TLD in the mouse phantom
was 0.792 (SD=0.006) relative to 60Co. This factor can be applied to validate dose
delivered in this model of animal irradiator. The feasibility of the independent peer
review system was demonstrated by verifying beam output and small animal
dosimetry for two institutions.
We established and commissioned a methodology for independent peer
review of mouse dosimetry for a commonly used animal irradiator. This
methodology can be used to characterize other commercially available orthovoltage
irradiators.
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Chapter 1: Introduction and Background
Background to the Problem
The results from pre-clinical research, i.e., animal studies, are used to assist in
the design of clinical trials for human subjects. Accurate and reproducible pre-clinical
radiation biology research is essential for designing meaningful clinical trials in
radiation oncology that will advance cancer treatments. As described in a recent
review article, the National Cancer Institute (NCI) is concerned with the lack of success
of recent clinical trials (Zakeri, Coleman, & Vikram, 2018). The article analyzed results
of recent prospective randomized trials in radiation oncology for clinical significance.
Notably and of concern, approximately half of the clinical trials were not proven to be
clinically significant, highlighting the need for improved clinical trial design, which
starts with improved pre-clinical research.
A recent NCI U01 funding opportunity announcement had explicit instructions
requiring accurate and reproducible dosimetry for the testing of targeted agents
administered with radiation therapy and chemotherapy in cell and animal studies
(National Institutes of Health, 2016). The program announcement emphasized the
importance of robust pre-clinical studies in order to improve the potential success of
human trials. In order for pre-clinical work to be robust, standardization is needed.
This need was emphasized in the program announcement, which explicitly stated, “In
radiation studies, as in other preclinical testing, there is a need for standardization of
assays, for the development of improved models, as well as a framework for crossvalidation of pre-clinical results.” The program announcement addressed specific
action items for improving standardization, including stating the “precise targeting,
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timing, and dosing of radiation” and “ensuring accuracy and consistency of irradiation
protocols through [National Institute of Standards and Technology (NIST)]-traceable
dosimetry testing and ongoing validation, and detailed, translatable reporting of
irradiation set-up details.”

Not only does the announcement state specific

methodology, but a mandatory component of the modular budget was the inclusion of
a minimum of fifty thousand dollars towards NIST-traceable dosimetry. This is the first
time that such explicit details regarding radiation dosimetry and standardization have
been specifically defined in an NCI program announcement for molecularly targeted
therapy in animals and cells. This paradigm shift toward including mechanisms to
ensure accurate radiation dosimetry in pre-clinical studies suggests that the NCI is
concerned that failures in recent clinical trials are related to the lack of accurate and
consistent dosimetry in those studies.
Several studies have investigated the need for improved dosimetry reporting in
pre-clinical studies in order to improve the translation of preclinical research into the
clinic.

One report investigated preclinical studies for ten popular radiation dose

enhancers (Stone et al., 2016). The report evaluated 125 preclinical studies, 104 in
vitro and 51 in vivo. The studies’ methods were evaluated for clarity. A subset of the
methods analyzed was reporting of radiation parameters, including: radiation source
type, energy, dose rate, setup, and equipment calibration. The percentages of in vitro
and in vivo papers for which these radiation parameters were clearly reported are
summarized in Table 1. The lack of reporting of irradiation parameters is concerning
for several reasons. First, it makes it impossible for other researchers to reproduce
the experiment and compare experimental results. Second, lack of reporting makes
it unclear whether the dosimetry within the studies was accurate. The report’s review
2

highlights these two key concerns, stating, “with deficiencies in reporting dosimetry
and irradiation setup, it was not possible to know whether researchers had accounted
for such factors as dose from backscatter, uniformity of dose across the radiation field
or through the depth of the tumor, absorption by overlying culture medium, culture
vessel or tissues, and whether dosimetry had been carried out under the same
conditions as the experimental setup or was traceable to equipment calibrated by
NIST. Lack of this information makes it impossible to replicate the studies and to
compare results within and among laboratories.” The results of pre-clinical research
on very complex radiation biology mechanisms have no meaning if the dosimetry is
incorrect and others cannot reproduce the results. This is of particular concern for
radiation threshold experiments, where the absorbed dose associated with a radiationinduced effect is being reported, e.g., erythema onset (Desrosiers et al., 2013).

Studies that Reported the Specified Parameter (%)
Radiation Parameter
In Vitro Studies

In Vivo Studies

3

Source

86

80

Energy

81

63

Dose rate

62

57

Setup

24

55

Equipment Calibration

8

20

Table 1. Reporting of radiation parameters in a survey of one hundred and twentyfive preclinical studies1
Concerns regarding standardization in animal studies led the NCI, the
National Institute of Allergy and infectious Diseases (NIAID), and NIST to host a
workshop on Radiation Dosimetry Standardization in Radiobiology in September
2011 (Desrosiers et al., 2013). There were two major goals of this workshop. The
first was to highlight the need for dosimetry standardization, and the second was to
discuss the necessary efforts for improving standardization in the future. Workshop
participants put forth a list of recommendations for improving standardization. Key
takeaways from these recommendations were the need for collaboration among
biologists and physicists, the need for dosimetry comparison programs, and
suggestions for the dosimetry content that should be included in radiobiology
publications. In regards to the latter takeaway, participants proposed four categories
of dosimetry information be mandated for publication of pre-clinical trial data for

1

Table 1 is compiled from:
Stone Helen B, Bernhard Eric J, Coleman C Norman, Deye James, Capala Jacek,
Mitchell James B, Brown J Martin. Preclinical data on efficacy of 10 drug-radiation
combinations: Evaluations, concerns, and recommendations. Transl Oncol.
2016;9(1):46-56. doi:10.1016/j.tranon.2016.01.002
4

studies involving radiation therapy: (1) absolute dosimetry and beam calibration (2)
methodology for determination of absorbed dose within research subjects, (3)
specification of the radiation source, and (4) irradiation details.
A major discussion topic at the 2011 workshop was the need for dosimetry
comparison programs, i.e., independent peer review, specifically for radiation biology.
Independent peer review for dosimetry is well established for megavoltage (MV) linear
accelerators. For MV linear accelerators, independent peer review is available from
several different agencies/groups including the International Atomic Energy Agency
(IAEA) (Izewska, Bera, & Vatnitsky, 2002); European Organization for Research and
Treatment of Cancer (EORTC) (Hurkmans et al., 2016); Australian Clinical Dosimetry
Service Radiotherapy Trials Quality (ACDS) (Williams et al., 2012); Japan Clinical
Oncology Group (JCOG) (Okamoto et al., 2018); Radiotherapy Clinical Trials: Quality
Assurance Group (RTTQA) (Clark et al., 2015); University of Wisconsin Radiation
Monitoring by Mail (UWRMM), (Yegingil et al., 2012,;“Radiation Monitoring by Mail
Services,” n.d.); MD Anderson Radiation Dosimetry Services (RDS) (Aguirre et al.,
2003); and Imaging and Radiation Oncology Core (IROC) Houston QA Center
(Aguirre et al., 2003;,Ibbott, 2010). However, there is no parallel service offered for
small animal irradiators.

The University of Wisconsin Accredited Dosimetry

Calibration Laboratory (UWADCL) has assisted with a couple of small pilot mail audits
of beam outputs for small animal irradiators. One study by Seed et al. found that only
four out of seven institutions were able to deliver doses within five percent of the
prescribed dose for their radiation biology setups (Seed et al., 2016). The second
study by Pedersen et al. tested twelve beams at ten different institutions, and found
that only five out of the twelve were within five percent accuracy (Pedersen et al.,
5

2016). Furthermore, six out of the twelve beams were outside of a ten percent
accuracy criterion. These studies demonstrate a clear need for a widely available
independent peer review system for small animal irradiators used for radiobiological
pre-clinical studies.
The market for small animal irradiators has recently shifted from the use of
isotope source irradiators to X-ray orthovoltage irradiators. However, this shift in
technology has not been accompanied by new procedures or any formal
recommendations regarding calibration of such units. Orthovoltage beam calibration
recommendations were defined by the American Association of Physicists in Medicine
(AAPM) Task Group 61 (TG-61) (Ma, 2001). However, TG-61 was published more
than 15 years ago (2001) before current orthovoltage “cabinet” irradiators were widely
used. There are many challenges related to applying TG-61 protocol within the
confines of cabinet irradiator geometries as opposed to the clinical external beam
orthovoltage radiotherapy units for which the protocol was developed. The lack of
calibration protocols for this specific new technology reinforces the importance of the
workshop recommendations for the involvement of a physicist in the design and
implementation of radiation biology research and the need for dosimetry comparison
programs. In the University of Wisconsin Accredited Dosimetry Calibration Laboratory
mail audit studies referenced above, several of the institutions tested were operating
orthovoltage small animal irradiators. In the study by Seed et al., three of the labs
were operating x-ray irradiators (Seed et al., 2016). Only one of the three labs passed.
One of the two failing labs had dose errors as large as forty-two percent. None of the
orthovoltage labs had physicists on staff, and two out of the three were reliant on
manufacturer’s specifications for dosimetry. In the study by Petersen et al., five out
6

of the twelve facilities were x-ray facilities. Only one of these five x-ray facilities
passed.

The average deviation between the measured and intended dose was

seventeen percent.

Orthovoltage Small Animal Irradiators
The need for dedicated precision irradiators for pre-clinical research and the
subsequent onset of orthovoltage small animal irradiators is best described in a
review article by Verhaegen et al., detailed below (Verhaegen, Granton, &
Tryggestad, 2011).
The past twenty years have seen major advancements in radiation therapy.
Modern treatments utilize beam modulation and image-guidance, resulting in
improved tumor control and reduced normal tissue complications. These
technological advancements in radiation therapy were not immediately matched by
subsequent advancements in radiobiology research. Therefore, modern treatments
were adapted without validation in animal models. However, in the past decade,
several research groups developed dedicated precision small animal irradiators that
make it possible to mimic modern radiotherapy in small animals (Verhaegen et al.,
2011).
In order to mimic human responses using small animals, both the radiation
beam size and energy needed to be appropriately scaled. Treating small animals
using clinical megavoltage (MV) photon beams is not appropriate and does not
resemble human treatments, although this methodology was used to derive much of
the available clinical guidelines on tumor control probability and normal tissue
complication probability. MV beams result in dose build-up/down gradients at tissue
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interfaces due to electronic disequilibrium. The scale of these gradients is on the
order of the size of small animals, making it impossible to deliver a uniform dose to
the tumor in a mouse using megavoltage energies. Most of the dedicated precision
small animal irradiators that are being widely used today contain an x-ray source,
although some use radioactive sources (Verhaegen et al., 2011). The dominance of
orthovoltage irradiators over active source irradiators for pre-clinical research is likely
attributed to several factors, including: the ability to select a desired treatment
energy from a wide range of energies, the strict regulations associated with
operating an active source irradiator, and the need to replace radioactive sources
due to decay. Verhaegen et al. describes the advantages of using orthovoltage
energies to treat small animals. Unlike MV photon beams, orthovoltage beams
experience minimal dose buildup effects at material interfaces, making them ideal for
treating small animals. Another advantage of orthovoltage beams is their sharp
radial dose profile, reducing the dose delivered to surrounding normal tissues. This
advantage is critical in small animals given the small size of the target and close
proximity of normal structures (Verhaegen et al., 2011).
State of the art orthovoltage small animal irradiators are commercially
available from Precision X-Ray (North Branford, CT) and Xstrahl Medical & Life
Sciences (Camberley, Surrey) (Butterworth, Prise, & Verhaegen, 2015). Precision
X-Ray’s most advanced irradiator on the market is the X-RAD Small Animal
Radiotherapy (SmART) unit (Figure 1), the successor of the X-RAD 225Cx. The
major competitor for the X-RAD SmART is the Xstrahl Small Animal Radiation
Research Platform (SAARP) (Figure 2). Both irradiators achieve sub-millimeter
targeting accuracy, an important requirement given that entire anatomical structures
8

in mice and rats are on the order of centimeters. The single x-ray tube in these
irradiators is used for both imaging and therapy via interchangeable filter packs,
enabling image-guided treatments. They are capable of fast (approximately one
minute) precision imaging via cone beam computed tomography (CBCT) by either
rotating the x-ray source and detectors or rotating the animal. Both of these systems
also offer bioluminescent optical imaging (Verhaegen et al., 2011). Researchers can
inject Luciferase, a light emitting enzyme, into small animals in order to visualize
tumor or disease (Sadikot, 2005). The optical photons are detected using chargecoupled device (CCD) cameras. Incorporating fast, functional imaging capabilities
into small animal research platforms is commendable. Bioluminescent optical
imaging has enabled researchers to assess treatment response and study adaptive
radiation therapy. However, researchers should be aware of the limitations of
bioluminescent optical imaging in regards to signal localization. Positron emission
tomography (PET) scans have far superior localization due to coincidence detection.
Previously acquired PET scans and scans from other modalities can be fused with
bioluminescent optical imaging and CBCT images. The precision on-boarding
imaging, along with the ability to fuse previously acquired Digital Imaging and
Communications in Medicine (DICOM) images from other modalities, enable
targeting accuracies on the order of 100-200 m (Verhaegen et al., 2011; “X-RAD
SmART Small Animal Image Guided Irradiation System,” n.d.).

9

Figure 1. Precision X-Ray’s X-RAD Small Animal Radiotherapy (SmART) unit2

2

Figure 1 reproduced from: http://www.pxinc.com/news/press-releases/researchersembrace-precision-x-ray%E2%80%99s-next-generation-igrt-system.html. Accessed June 7,
2018.
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Figure 2. Xstrahl's Small Animal Radiation Research Platform (SAARP)3
Butterworth et al. reports on the capabilities of current small animal imageguided radiotherapy devices. Both Precision X-Ray and Xstrahl provide research
platforms that can plan and deliver clinically relevant treatments that align with

3

Figure 2 adapted from: https://xstrahl.com/life-science-systems/muriplan/. Accessed June
7, 2018.
11

Phase 1 clinical trials. Precision X-Ray offers a treatment planning software called
SmART-Plan, developed at MAASTRO clinic (Maastricht, Netherlands). SmARTPlan computes dose using CBCT images and Monte Carlo simulations. Xstrahl’s
treatment planning software is called Muriplan. It utilizes graphical processing units
(GPUs) to compute dose based on advanced superposition convolution algorithms
(Butterworth et al., 2015). Both platforms are capable of planning and treating using
static beams or complex arcs. Non-coplanar therapy is also possible, as both the
SmART and SARRP units have rotating animal platforms. Both companies offer
motorized collimators, enabling intensity modulated radiation therapy (IMRT). The
SARRP unit is capable of respiratory gating combined with temperature and heart
rate monitoring (“X-RAD SmART Small Animal Image Guided Irradiation System,”
n.d.; “Small Animal Radiation Research Platform,” n.d.).
While precision orthovoltage small animal irradiators are transforming
translational radiobiology, they lack many of the capabilities of modern MV linear
accelerators. Small animal irradiators are not equipped with multi-leaf collimators.
Furthermore, inverse treatment planning and automated contouring are not yet
available. Of greatest concern, quality assurance guidelines and methodologies for
small animal irradiators are lacking. Without processes and procedures for testing
dosimetric accuracy and reproducibility, experimental results can’t be verified.

Thermoluminescent Dosimetry
Thermoluminescent dosimeters (TLD) are solid state, integrating passive
dosimeters (Attix, 1986; Khan & Gibbons, 2014). They are commonly used in
clinical practice for skin dose measurements, brachytherapy dose-rate constant
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measurements (Nunn et al., 2008), and of particular relevance to our work,
independent peer review. TLD are both practical and appropriate for independent
peer review because of their small size, high dosimetric accuracy, and their ability to
“hold” dose for readout at a later time.
The American Association of Physicists in Medicine (AAPM) Task Group 191
(TG-191) report provides recommendations to the medical physics community on the
appropriate use of luminescent dosimeters in a clinical setting. It details the theory of
TLD, phosphor crystals containing small impurities (Kry et al., n.d.). These
imperfections are utilized to measure dose. When energy in the form of ionizing
radiation is deposited in TLD, charges are excited and can become trapped in the
crystal impurities. During readout, these trapped charges are released by
stimulating the crystal with heat, resulting in the emission of visible light. Resulting
luminescence is detected with a photomultiplier tube (PMT). Finally, correction
factors are applied to relate the energy collected to the dose delivered to the TLD
(Kry et al., n.d.).
TLD signal can be converted to dose using a calibration factor defined for a
user’s specific irradiation and readout conditions. It is typically defined using TLD
standards, or TLD irradiated to a known dose under specific irradiation conditions in
reference energy beam. TLD standards are then used to determine the calibration
factor, also referred to as the sensitivity, for each reading session. This factor
directly relates signal to dose under standard conditions. As in TG-51 methodology,
the dose under experimental conditions is calculated using a series of correction
factors relating the experimental conditions to the TLD standards conditions
(Almond, Biggs, & Hanson, 1999). The following equation is used:
13

𝐷 = 𝑀𝑐𝑜𝑟𝑟 𝑁𝑘𝐹 𝑘𝐿 𝑘𝑄 𝑘𝜃 ,
where Mcorr is the corrected reading collected during the TLD readout process, N is
the system calibration coefficient referred to above, kF is the fading correction factor,
kL is the linearity correction factor, kQ is the beam quality correction factor, and k is
the angular correction factor. The details of each term in the equation are discussed
further below (Kry et al., n.d.).
For TLD powder, the mass of the powder needs to be accounted for since the
amount of powder is directly related to the luminescence. The corrected reading is
reported as signal per unit mass. The reading may be corrected for background
signal by reading a TLD that has not been irradiated. The system calibration
coefficient, N, is often defined for each reading session by reading TLD standards.
The calibration coefficient for the reading session is determined by dividing the dose
delivered to the standards by the corrected reading (Kry et al., n.d.).
Each of the “k” correction factors relates the experimental conditions to the
standards conditions since the calibration coefficient is only valid for the irradiation
and reading conditions of the standards. The exponential decay of the TLD signal
with time is referred to as fading. Fading can be explained by the spontaneous
release of electrons occupying shallow traps at room temperature. A large amount
of the TLD signal is lost in the first 24 hours after irradiation. Fading stabilizes after
a couple days, when the majority of the low energy traps have emptied. Because of
the exponential decay fading relationship, TLD are usually read about a week after
irradiation, when the signal has stabilized. The fading correction factor, kF, is
needed if the time between irradiation and reading for the experimental TLD is
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different than that of the standards. This correction factor, as well as the other
correction factors, are commissioned for each batch of TLD. A batch of TLD is a
group created from the same crystal. Once the correction factors for the batch are
determined, they can be assumed to be uniform (Kry et al., n.d.).
The linearity correction factor, kL, refers to the varying sensitivity of signal with
the dose delivered. There is a linear response between dose and signal at low
energies (up to 4 or 5 Gy). However, the response becomes supralinear and
eventually flat as the dose is increased. This relationship is measured and plotted
during batch commissioning. The linearity correction factor corrects for the
differences in sensitivity for the dose delivered to the experimental TLDs versus the
standards (Kry et al., n.d.).
The energy correction factor, kQ, accounts for the change in TLD sensitivity
with beam quality. Of particular relevance to this study, TLD over respond at low
energies (in the orthovoltage range) relative to megavoltage energies. Thus, when
TLD are used to measured dose in orthovoltage irradiators, it is critical to fully and
accurate characterize kQ. There are two components of the energy correction factor,
presented by the TG-191 committee: an intrinsic energy dependence and a mediumdependent energy dependence. The intrinsic energy dependence is the change in
signal per dose to the detector versus energy. It accounts for how radiation interacts
with the crystal at different energies, i.e., the different trapping and recombination
mechanisms in the phosphor crystal that occur at different energies. The mediumdependent energy dependence accounts for the fact that the TLD material is used to
determine dose to a material of interest (usually tissue, water, or muscle). The
relationship between the dose delivered to TLD and the dose delivered to
15

surrounding tissue changes with energy as a result of differences in mass
attenuation coefficients and stopping-power ratios (Kry et al., n.d.). The large overresponse of TLD by up to 40% in the diagnostic range is primarily a result of this
phenomenon. The photoelectric effect is the dominating radiation interaction
mechanism at low energies. Its probability is related to the third power of the atomic
number (Z3) (Khan & Gibbons, 2014). The most commonly used TLD material, TLD100, is composed of lithium fluoride (LiF). LiF has an atomic number of 8.3, as
compared to 7.2 for soft tissue (Scarboro et al., 2011). Therefore, the probability of
the photoelectric effect in LiF is 1.53 times that in soft tissue. The energy correction
factor is not separated into its two components when measured. An overall energy
correction factor corrects for the differences in TLD sensitivity for the experimental
versus standards beam quality.
Lastly, the angular correction factor is needed if the orientation of the incident
radiation on the experimental TLD is different from that of the standards. However,
because the TLD capsules used in this study are cylindrically symmetric, an angular
correction factor is not needed.

Radiation Dosimetry Services (RDS) Independent Peer Review
MD Anderson RDS is one of several organizations around the world that
offers independent peer review in the form of mail audits. Mail audits play a major
role in improving the quality of radiation therapy centers. RDS offers several
independent peer review services including: beam output checks for external
radiation therapy machines, dose verification for total body and total skin
procedures, and dose verification for blood irradiators used by blood banks
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(“Radiation Dosimetry Services: Mailed Thermoluminescent Dosimeters (TLD) for
Quality Assurance,” n.d.). Orthovoltage irradiators are among the external radiation
therapy machines that RDS offers beam output checks for. Orthovoltage output is
checked by irradiating TLD capsules on top of an irradiation stand. With the
increased use of small animal irradiators in the past several years, RDS has
received beam output check requests for these dedicated pre-clinical cabinet
irradiators. Over the past five years, RDS has been monitoring beam output of XRAD irradiators from several institutions with a passing criterion of 10%.
Independent peer review of beam output ensures that cabinet irradiators are
properly calibrated. However, RDS does not currently have the ability to check small
animal dosimetry. Developing and commissioning a mouse phantom for
independent peer review in small animal irradiators would enable RDS to more
thoroughly test the dosimetry of pre-clinical studies.

Statement of the Problem
In the past decade, dedicated precision animal irradiators have become
widely available. Today, they are commonly used for pre-clinical research. The
results from radiation biology studies are used to design clinical trials. However, the
accuracy and reproducibility of pre-clinical research is lacking. There is no widely
available service for independent peer review for small animal irradiators. Small
scale preliminary studies suggest that approximately 65-80% of institutions operating
orthovoltage irradiations have large dosimetric inaccuracies (Pedersen et al., 2016;
Seed et al., 2016). The availability of independent peer review for small animal
irradiators would improve dosimetric standardization in radiation biology
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experiments, leading to improved success of clinical trials and advancements in
modern radiotherapy.

Project Objective
The overall objective of this project was to develop and commission an
independent peer review system for small animal irradiators. In particular, we focused
on a commonly used animal irradiator, the X-RAD 225Cx (Precision X-Ray, North
Branford, CT). Once developed, this methodology can be further expanded to include
other types of commercially available irradiators.

Hypothesis
An independent peer review system for a small animal irradiator can be developed
that has a total (1-sigma) uncertainty of less than ±10%.

Specific Aims
The four specific aims below were designed to test the hypothesis.
1. To design a mouse phantom that is appropriate for a mailable peer review TLD
audit service.
2. To characterize the half value layer of the animal irradiator, and to determine dose
in the animal irradiator using an ion chamber and following AAPM TG-61 protocol.
3. To characterize the energy correction factor for TLD in the mouse phantom in the
small animal irradiator.
4. To conduct a feasibility study of the developed audit service by sending the
phantoms to at least two sites to verify the output of their irradiators.
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Chapter 2: Development of the Independent Peer Review
Service
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Mouse Phantom Design
Methods
3D Printed Mouse Phantom
The first approach to creating a mouse phantom was to utilize 3D printing
technology. A computed tomography (CT) scan of an average sized laboratory
mouse was obtained from a radiation biology laboratory at our institution. OsiriX
(Bernex, Switzerland) software was used to import the CT scan and create a 3D
model of the mouse. The mouse model was edited using MeshLab software (Pisa,
Italy) to remove the nose cone used to anesthetize the mouse. The unedited and
edited versions of the mouse model are shown in Figures 3a and 3b, respectively.
Simplify3D software (Cincinnati, Ohio) was then used to convert the model into a
printable file. The mouse phantom was printed in two pieces using NinjaFlex
material on a commercial 3D printer.

(a)

(b)

Figure 3. Unedited (a) and edited (b) mouse model in MeshLab
Machined Mouse Phantom
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Based on preliminary results (see section 3D Printed Mouse Phantom below),
we determined that a 3D printed phantom was not sufficiently robust for a mailable
audit system and chose to move forward with a stylized, machined phantom made of
high impact polystyrene (HIPS). Such phantoms have been well characterized by
the MD Anderson RDS, which has used stylized HIPS for ten years for its peer
review service of orthovoltage energy blood irradiators.
We aimed to develop a mouse phantom with dimensions similar to a typical
mouse used in radiation biology experiments. Thus, we measured the dimensions
of five C57BL/6J strain mice (3 male and 2 female) at 8, 10, and 12 weeks of age.
The following measurements were taken: whole-body length (from the tip of the nose
to the start of the tail), head length, head depth, head width, chest length, chest
depth, chest width, flank depth, and tail length. The measurements are shown in
Table 2.
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Age

id

8
weeks

m1
m2
m3

whole head head head chest chest chest flank
tail
body length depth width length depth width depth length
length (mm) (mm) (mm) (mm) (mm) (mm) (mm) (mm)
(mm)
12.0
11.6
11.9
11.8
13.4
11.7
12.6
12.2
12.1
14.1
12.8
13.0
12.0
12.5

15.3
14.7
15.9
15.3
14.7
17.5
16.1
15.9
15.2
15.2
15.4
16.4
15.0
15.7

29.7
27.8
19.2
25.6
26.1
27.7
26.9
31.6
26.1
27.7
28.5
26.2
26.6
26.4

15.2
13.8
14.6
14.5
17.5
15.1
16.3
15.1
15.3
15.2
15.2
14.2
16.8
15.5

19.7
20.0
19.1
19.6
19.7
19.1
19.4
23.4
23.5
22.6
23.2
23.2
21.4
22.3

13.5
12.2
11.5
12.4
13.2
12.1
12.7
13.0
15.3
13.0
13.8
12.2
14.6
13.4

65.6
67.3
69.1
67.3
65.3
69.2
67.3
70.5
68.6
71.6
70.2
70.8
74.7
72.8

94.8
28.7
12.8
88.9
29.1
12.0
89.9
28.9
13.7
91.2
28.9
12.8
f1
84.2
26.5
10.8
f2
85.3
27.4
12.4
84.8
27.0
11.6
Table 2. Measured mouse dimensions4

15.2
16.3
17.0
16.2
13.8
15.0
14.4

26.4
16.3
25.4
22.7
24.3
25.3
24.8

17.0
14.9
17.1
16.3
15.5
14.1
14.8

25.0
24.1
26.2
25.1
20.4
22.7
21.6

14.4
14.1
12.7
13.7
12.8
13.2
13.0

89.7
70.2
70.7
76.9
67.0
70.4
68.7

f1
f2
10 weeks m1
m2
m3
f1
f2
12 weeks m1
m2
m3

87.5
83.9
85.6
85.7
80.5
82.1
81.3
90.7
90.4
87.6
89.6
85.3
88.3
86.8

27.5
27.0
27.5
27.3
27.2
28.1
27.7
26.8
28.0
26.8
27.2
26.3
26.2
26.3

The average measurements were used to determine appropriate dimensions
for the symmetric mouse phantom. The shape of the mouse was simplified using a
partial cylinder of diameter 25 mm to represent the body and a cone to represent the
head. The height of the phantom was 20 mm, and the length was 85 mm. The
basic dimensions of the phantom are shown in Figure 4. The lengths of the phantom

4

male and female mice indicated with id that begins with m or f, respectively
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body and head are illustrated in Figure 4a. The height and width of the phantom are
shown (as viewed from the backside) in Figure 4b.
(b)
(a)

Figure 4. High impact polystyrene mouse phantom dimensions
Results
3D Printed Mouse Phantom
The NinjaFlex 3D printed mouse phantom is shown in Figure 5. The
approach of 3D printing the phantom was not further pursued due to two key
limitations. First, a key aspect of mailable audits is that the phantoms be robust in
terms of mechanical integrity because they will undergo thousands of shipments and
irradiations. The soft 3D printed phantom material, along with the small size of the
extremities were not sufficiently robust. Second, the energy dependence of the
material must be well defined for beam energies in which it will be irradiated. While
the 3D printed material had been characterized for megavoltage photon and electron
beams (Craft et al., 2018), it had not been characterized in orthovoltage beams.
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Figure 5. 3D printed mouse phantom
Machined Mouse Phantom
Two mouse phantoms were machined from HIPS; one accommodated three
thermoluminescent dosimeters (TLD) and the other an Exradin A1SL 0.053 cc ion
chamber (Standard Imaging, Middleton, WI) for cross-comparison with the TLD. The
phantoms were designed so that the centroid of the ion chamber is at the same
location as the center of the TLD powder in the middle TLD capsule. The model of
the mouse phantom that was designed to accommodate TLD and an ion chamber
are shown in Figure 6a and 6b, respectively.

(a)

(b)

Figure 6. Model of high impact polystyrene thermoluminescent dosimeter (a) and
ion chamber (b) mouse phantoms
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The machined mouse phantoms constructed of HIPS are robust and user
friendly, ideal for a mail audit service. Both the TLD and ion chamber phantoms,
shown in Figure 7a and 7b, respectively, contain crosshairs for alignment with the
irradiator’s isocenter using the unit’s wall lasers. The TLD phantom was constructed
to ensure a snug fit for the TLD capsules and to allow easy loading and unloading of
the capsules between irradiations. Holes of very small diameter behind the TLD
capsule holes enable the capsules to be unloaded with the tip of a paperclip.

(a)

(b)

Figure 7. High impact polystyrene thermoluminescent dosimeter (a) and ion
chamber (b) mouse phantoms

Irradiation Stand Design
Methods
An irradiation stand was designed to ensure a reproducible set-up for the mail
audit service. Note that in this investigation, we focused on designing a stand for the
X-RAD 225Cx small animal irradiator. However, an analogous method could be
followed to design irradiation stands for other manufacturers and models. A box
shaped irradiation stand was designed to allow users to align the mouse phantom to
the irradiator’s isocenter. Acrylic was selected as the material for the stand because
it has a low scatter cross section and is translucent, ensuring optimal visibility during
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setup. A foldable design was chosen to reduce shipping costs for the service. The
height of the stand needed to be such that the center of the mouse phantom would
align with the beam isocenter. To determine the appropriate stand height, we
therefore measured the distance from the metal plate at the base of the irradiator to
the isocenter.
Results
A foldable irradiation stand was created as a platform for the developed
mouse phantom. The foldable irradiation stand was constructed out of sheets of
Lexan 0.16 cm thick. The stand is easily assembled using tape (Figure 8). The
distance from the metal plate at the base of the irradiator to the isocenter at our
institution was measured to be 28.8 cm. However, the variation in isocenter
distance for different units, even of the same model, has not been characterized.
Thus, to accommodate for possible variation in this distance, we designed a stand
with a nominal height of 26 cm, to which the user can add sheets of acrylic or paper
to achieve the appropriate height in their unit. A stand width of 15 cm was selected
because it does not interfere with the 10 cm by 10 cm irradiation field. The platform
that sits on top of the stand is 18 cm by 18 cm. The developed irradiation stand
ensures reproducibility in the irradiation setup for independent peer review.
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Figure 8. Assembled irradiation stand
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Chapter 3: Commissioning the Independent Peer Review
System
Determination of True Dose in the Animal Irradiator
Methods
Measuring Beam Output for Small Animal Irradiator
Mechanical Isocenter Check
Because beam output is determined at the irradiator’s isocenter, a
mechanical isocenter check was performed prior to taking any output
measurements. An in-house isocenter position indicator (pointer) was inserted into
the accessory tray that was used for this test. As the source tube was rotated
through 360 degrees, coincidence of the lasers with the tip of the isocenter pointer
was checked. Agreement within 1 mm between the lasers and isocenter pointer
throughout the gantry rotation indicated that the mechanical isocenter is correctly
located. Figure 9 illustrates the coincidence of the laser intersection with the
isocenter pointer when the gantry is positioned so that the beam axis is vertically
downwards.
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Figure 9. Mechanical isocenter check

Half-Value Layer Measurements
Application of the TG-61 protocol requires accurate measurement of halfvalue layer (HVL) under narrow-beam geometry (Ma, 2001). An in-house narrowbeam collimator was designed (by R. Tailor) to achieve true narrow-beam geometry
in the small animal irradiator. The collimating device consists of two Cerrobend
plates of 1.6 mm thickness, separated by a vertical distance of 3.3 cm, with a 1.0 cm
diameter aperture. The removable collimator (Figure 10) was designed to be placed
on top of a Styrofoam stand (Figure 11), which houses the attenuating material and
the ion chamber (Exradin A1SL) according to good geometric conditions, reducing
the amount of scattered radiation reaching the detector. The narrow-beam half-value
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layer for the X-RAD 225Cx was measured using copper and aluminum sheets for
the maximum beam quality, 225 kVp and 13 mA, over the course of several months.

Figure 10. Schematic diagram of the narrow-beam collimator
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Figure 11. Schematic diagram of the narrow-beam collimator on top of the
Styrofoam stand5
Air-kerma Calibration and TG-61 In-Air Method
Reference dosimetry of clinical orthovoltage irradiators is described in the
AAPM TG-61 protocol (Ma, 2001). The TG-61 report contains two dosimetry
methods, “in-air” and “in-phantom”. Both methodologies are based on an air-kerma
standard, with measurements performed with an ionization chamber that has been
calibrated in air in terms of air-kerma at a standards laboratory. The in-phantom
method determines absorbed dose to water at 2 cm depth within a water phantom
that is at least 30 x 30 x 30 cm3. We used the in-air methodology to calibrate the X-

5

Dimensions are in centimeters unless stated otherwise
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RAD 225Cx at our institution because its inner dimensions could not accommodate
an appropriately sized phantom. Specifically, we measured dose at a reference
point in air to determine absorbed dose to water at the surface of a water phantom.
The A1SL ion chamber used for determining TG-61 beam output was
calibrated for air-kerma at the University of Wisconsin ADCL. An air-kerma
calibration factor relates the corrected ion chamber reading to the air-kerma, as
shown in Equation 1:
Equation 1: 𝑁𝐾 =

𝐾𝑎𝑖𝑟
𝑀

where NK is the air-kerma calibration factor for a given beam quality, Kair is the airkerma at the reference point, and M is the corrected ion chamber reading at the
reference point (Ma, 2001). Our A1SL ion chamber was calibrated for four different
tungsten anode orthovoltage beam qualities, listed in Table 3. Air-kerma calibration
factor was plotted as a function of HVL for the four beam qualities (Figure 12). The
air-kerma calibration factor for the X-RAD 225Cx was selected from the fitted curve
(Figure 12) for the unit’s measured HVL.

Beam
Quality

HVL1
(mm
Al)

HVL1
(mm
Cu)

Air Kerma
Rate
(mGy/sec)

14.8

1.63

UW80-M

Added
filter
(mm Al
or Cu)
1.00 Al
+ 1.01
Cu
3.0 Al +
0.10 Cu
2.75 Al

UW-60M

1.50 Al

UW200-M

UW120-M

1.930

Air Kerma
Calibration
Coefficient
(Gy/C)
5.375 x 108

Exposure
Calibration
Coefficient
(R/C)
6.136 x
1010

6.77

2.365

5.355 x 108

3.00

1.821

5.453 x 108

1.65

1.796

5.615 x 108

6.113 x
1010
6.225 x
1010
6.410 x
1010
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Table 3. Air-kerma calibration coefficients measured at the University of Wisconsin
Accredited Dosimetry Calibration Laboratory

5.65E+08
5.60E+08

Nk (Gy/C)

5.55E+08
5.50E+08
5.45E+08
5.40E+08
5.35E+08
5.30E+08
1

2

3

4

5

6

7
8
9
HVL (mm Al)

10

11

12

13

14

15

Figure 12. Plot of air-kerma calibration factor (NK) versus half-value layer (HVL)

The TG-61 in-air method formula (Equation 2) was used to calculate
absorbed dose to water at the surface of a water phantom (Dw,z=0 ):
̅̅̅̅̅
𝜇𝑒𝑛 𝑤

Equation 2: 𝐷𝑤,𝑧=0 = 𝑀𝑁𝐾 𝐵𝑤 𝑃𝑠𝑡𝑒𝑚,𝑎𝑖𝑟 [(

𝜌

)

]

𝑎𝑖𝑟 𝑎𝑖𝑟

where M is the ion chamber reading (corrected for ion collection efficiency, polarity,
temperature and pressure, and electrometer accuracy) at the isocenter, NK is the airkerma calibration factor for the unit’s beam quality (shown in Figure 12), Bw is the
water phantom backscatter factor (TG-61, Table V), Pstem,air is the chamber stem
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̅̅̅̅̅
μen w

correction factor, and [(

ρ

)

]

is the mean mass energy-absorption coefficient

air air

ratio for water-to-air averaged over the incident photon spectrum (TG-61, Table IV)
(Ma, 2001). The experimental setup for TG-61 in-air measurements is shown in
Figure 13. The ion chamber was suspended in air at the isocenter with an in-house
plastic holder that attaches to the collimator. Measurements (60 seconds) were
taken in a field size of 10 cm x 10 cm, using 225 kVp tube potential, 13 mA current,
5 mm focal spot size, and 0.3 mm copper treatment filter.

10 x 10 cm2
cone

Plastic
holder

isocenter

A1SL
chamber

Figure 13. Photograph of experimental setup for Task Group 61 in-air calibration
Determining Dose in the Mouse Phantom
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As detailed in the section above, the TG-61 in-air calibration protocol
determines the absorbed dose to the surface of a water phantom. However, of
particular interest in developing independent peer review for small animal irradiators
is the absorbed dose in a mouse phantom.

The RDS defines the TLD reader

sensitivity factor using TLD standards irradiated in a mini-phantom in a Co-60 beam
to a known dose to muscle. Therefore, the dose to muscle at the location of the TLD
in the mouse phantom was needed to commission the TLD for our independent peer
review.
The air-kerma at the isocenter was calculated by rearranging equation 1 as the
product of the corrected ion chamber reading at the isocenter and the air-kerma
calibration factor for the X-RAD 225Cx beam quality. Because the ion chamber walls
are thick enough to provide charged particle equilibrium in the orthovoltage energy
range, the air-kerma is equivalent to the dose to air (Khan & Gibbons, 2014). Equation
3 was used to calculate dose to air at the isocenter.
𝐺𝑦

Equation 3: 𝐷𝑎𝑖𝑟 (𝐺𝑦) = 𝑀𝑐𝑜𝑟𝑟 (𝐶) ∗ 𝑁𝐾 ( 𝐶 )
The definition of “dose in free space” was then used to convert dose to air to dose to
an equilibrium mass of water (Khan & Gibbons, 2014), shown in Equation 4 below.
𝑢𝑒𝑛 𝑤

Equation 4: 𝐷𝑤𝑎𝑡𝑒𝑟,𝑓𝑠 = 𝐷𝑎𝑖𝑟 ∗ [(

)

𝜌

]

𝑎𝑖𝑟 𝑎𝑖𝑟

Because dose to muscle is of interest, dose in free space to water was converted to
dose in free space to muscle using Equation 5 below:
𝑢𝑒𝑛 𝑠𝑡𝑟𝑖𝑎𝑡𝑒𝑑 𝑚𝑢𝑠𝑐𝑙𝑒

Equation 5: 𝐷𝑠𝑡𝑟𝑖𝑎𝑡𝑒𝑑 𝑚𝑢𝑠𝑐𝑙𝑒, 𝑓𝑠 = 𝐷𝑤𝑎𝑡𝑒𝑟,𝑓𝑠 * (

𝜌

)

𝑤𝑎𝑡𝑒𝑟
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𝑢𝑒𝑛 𝑠𝑡𝑟𝑖𝑎𝑡𝑒𝑑 𝑚𝑢𝑠𝑐𝑙𝑒

where (

𝜌

)

is the free-in-air ratio of the mass energy-absorption

𝑤𝑎𝑡𝑒𝑟

coefficient of International Commission on Radiation Units and Measurements
(ICRU) striated muscle to water; these coefficients are listed in TG-61 (Table X) for
different biological tissues as a function of HVL. Finally, to convert from the dose in
free space to the dose in the mouse phantom, a “pseudo” tissue-air ratio (TAR) was
used. The TAR accounts for attenuation and scattering of the beam in the phantom.
It is defined as the ratio of the dose at a depth in a phantom (Dd) to the dose in free
space (Dfs) at the same point, Equation 6 (Khan & Gibbons, 2014).
𝐷

Equation 6: 𝑇𝐴𝑅 = 𝐷 𝑑

𝑓𝑠

The TAR was determined by taking the ratio of the ion chamber reading in the ion
chamber mouse phantom (Figure 14a) to the reading in-air (Figure 14b) at the
isocenter. It should be noted that TAR is typically quoted for a specified field size,
as the phantom was larger than the radiation field. However, in this case, the mouse
phantom is smaller than the radiation field size. Therefore, TAR was defined as the
ratio of the reading in the ion chamber mouse phantom for a field of 8.5 cm by 2 cm
to the reading in-air for a field of 10 cm by 10 cm measured at the isocenter. Once
the TAR was determined, the dose to muscle at the center of the mouse phantom
was determined by taking the product of the dose to muscle in free space and the
TAR, as shown in Equation 7.
Equation 7: 𝐷𝑠𝑡𝑟𝑖𝑎𝑡𝑒𝑑 𝑚𝑢𝑠𝑐𝑙𝑒,𝑚𝑜𝑢𝑠𝑒 = 𝐷𝑠𝑡𝑟𝑖𝑎𝑡𝑒𝑑 𝑚𝑢𝑠𝑐𝑙𝑒,𝑓𝑠 ∗ 𝑇𝐴𝑅
The doses above were converted to dose rates by taking the ratio of the dose to the
irradiation time, accounting for timer error. The mouse phantom dose rate was then
used to determine the irradiation time needed to deliver a specified dose to muscle
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of 300 cGy at the location of the TLD. The TLD mouse phantom was loaded with
three TLD, placed on the irradiation stand, and aligned to the unit’s lasers, shown in
Figure 15. The irradiation time was selected on the animal irradiator console and the
phantom was irradiated.

(a)

(b)

Figure 14. Experimental set-up for tissue-air ratio measurements
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Figure 15. Experimental setup for delivering a known dose to the
thermoluminescent dosimeters in the mouse phantom
Results
Small Animal Irradiator Beam Output

Figure 16 is a plot of the half-value layer measured with copper attenuating
sheets for each measurement date. The average narrow-beam half-value layer
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expressed in copper was 0.857  0.002 mm Cu. Figure 17 is the corresponding plot
for aluminum attenuating sheets. The average narrow-beam half-value layer
expressed in aluminum was 10.86  0.09 mm Al.

0.9

HVL (mm Cu)

0.88

0.86

0.84

0.82

0.8
1/1/18

2/1/18

3/4/18
4/4/18
Measurement Date

5/5/18

6/5/18

Figure 16. Results from narrow beam half-value layer measurements with copper
attenuating sheets
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12

HVL (mm Al)

11.5

11

10.5

10
1/1/18

2/1/18

3/4/18
4/4/18
Measurement Date

5/5/18
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Figure 17. Results from narrow beam half-value layer measurements with aluminum
attenuating sheets

Figure 18 is a plot of the TG-61 output, i.e., dose rate of absorbed dose to
water at the surface of a water phantom, measured on different dates. The average
output over a four-month time interval was 426.1  3.9 cGy/min.
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TG-61 Output (cGy/min)
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Figure 18. Task Group 61 orthovoltage beam output results

Dose rate in the mouse phantom
The average TAR was 1.075  0.01. Figure 19 is a plot of calculated dose
rate in the mouse phantom measured on different dates. The dose rate is reported
in dose to muscle. The average dose rate over a four-month time interval was 341.2
 1.2 cGy/min.

41

Mouse Phantom Dose Rate (cGy/min)
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Figure 19. Measured dose rate in the mouse phantom

Characterizing the TLD Energy Correction Factor
Methods
Method 1: Comparison of Ion Chamber Dose to TLD Dose in Small Animal Irradiator
The first method that we used to determine the TLD energy correction factor
in the mouse phantom was to compare the ion chamber dose to the TLD dose in the
mouse phantom. The dose rate in the mouse phantom was determined by taking
ion chamber measurements in the mouse phantom, as detailed above. A known
dose was delivered to TLD in the mouse phantom. The TLD were read at RDS
using a well-established independent beam output service, Radiation Dosimetry
Services (Houston, TX), with an uncertainty of less than 1.5% (Kirby, T.H., Hanson,
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W.F., Johnston, 1992). The energy correction factor, kQ, was calculated (Equation
8) by setting the ion chamber dose equal to the TLD dose, as shown below:
𝐷𝑇𝐿𝐷 = 𝑀𝑐𝑜𝑟𝑟 𝑁𝑘𝐹 𝑘𝐿 𝑘𝑄 𝑘𝜃
𝐷𝑖𝑜𝑛 𝑐ℎ𝑎𝑚𝑏𝑒𝑟 = 𝐷𝑇𝐿𝐷
𝐷

𝑐ℎ𝑎𝑚𝑏𝑒𝑟
Equation 8: 𝑘𝑄 = 𝑀 𝑖𝑜𝑛 𝑁𝑘
𝑘 𝑘
𝑐𝑜𝑟𝑟

𝐹 𝐿 𝜃

where Mcorr is the corrected reading collected during the TLD readout process, N is
the system calibration coefficient defined at a reference energy in Co-60, kF is the
fading correction factor, kL is the linearity correction factor, and 𝑘𝜃 is the angular
correction factor.
Method 1 was performed a total of 18 times over 5 different dates. At the
outset of each performance, the dose rate in the mouse phantom was determined by
ion chamber measurements. After the dose rate was determined, the mouse
phantom was loaded with three TLD and irradiated to a known dose. Three
irradiations were performed for each date, with the exception of six irradiations on
March 28, when method 2 was conducted. The TLD energy correction factor was
calculated for each irradiation.

Method 2: Comparison of TLD Signal from Small Animal Irradiator to Reference Co60

The second method that we used to calculate the energy correction factor
utilized the inherent definition of the energy correction factor: the ratio of the dose
per reading from irradiation at a given energy to the dose per reading from irradiation
at a reference energy, as represented in Equation 9 (Kry et al., n.d.):

43

𝐷𝑒𝑥𝑝

Equation 9: 𝑘𝑄 =

𝑀(𝑄)𝑒𝑥𝑝

⁄ 𝐷𝑟𝑒𝑓 .
𝑀(𝑄)𝑟𝑒𝑓

The second method for determining the energy correction factor was to compare the
signal from TLD irradiated in the mouse phantom in a reference Co-60 beam to the
signal from TLD irradiated in the mouse phantom in the small animal irradiator.
The TLD irradiations in the mouse phantom in Co-60 and the small animal
irradiator were performed on the same day. The TLD from both irradiations were
read in the same reading session a week later to control for fading and sensitivity.
The procedure for delivering a known dose to TLD in the mouse phantom in
the small animal irradiator is described in the section above. The procedure for
delivering a known dose to the TLD in the mouse phantom in Co-60 is detailed
below. First, the TG-51 calibration protocol was followed to calibrate the dose rate
of the Co-60 unit (Almond et al., 1999). Measurements were taken in a 30x30x30
cm3 water tank at a depth of 10 cm with an 80 cm source to surface distance (SSD)
with an Exradin Model A12 0.64 cc farmer type chamber (Standard Imaging,
Middleton, WI) centered in a 10 x 10 cm2 field size. The measurements taken at 10
cm depth in the water tank were converted to dose rate using the following equation
from TG-51 (Almond et al., 1999):
Equation 10: 𝐷𝑤𝑄 =

𝐶𝑜−60
𝑀𝑘𝑄 𝑁𝐷,𝑤

𝑡𝑠𝑒𝑡 −𝑡𝑒𝑟𝑟𝑜𝑟

where Dw is the dose rate to water at the measurement point in water; M is the ion
chamber reading corrected for incomplete ion collection efficiency, polarity effects,
𝐶𝑜−60
temperature and pressure, and the electrometer accuracy; 𝑁𝐷,𝑤
is the absorbed

dose to water calibration factor for the ion chamber (determined at a standards
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laboratory); kQ is the beam quality factor, which is equal to one because the
measurements are performed in the same energy that the calibration coefficient is
defined in; tset is the time set on the timer, and terror is the timer error.
Once the calibration at 10cm depth was completed, we used the following
procedure was followed to convert dose at 10 cm depth in a water phantom to dose
at 1 cm depth in the mouse phantom. First, the dose rate at 1 cm in the water
phantom (D1 cm) was determined using published Co-60 percent depth doses (PDD)
for the appropriate SSD and field size (Aird et al., 1996):
𝑄

Equation 11: 𝐷1 𝑐𝑚 =

𝐷𝑤 ∗𝑃𝐷𝐷1 𝑐𝑚
𝑃𝐷𝐷10 𝑐𝑚

.

Next, the dose rate in full phantom was related to the dose rate in the mouse
phantom by taking measurements with the A1SL ion chamber at 1 cm in the water
tank and at 1 cm in the mouse phantom. The ratio of these readings is the ratio of
the backscatter factors, shown in Equation 12:
Equation 12: 𝐵𝑟𝑎𝑡𝑖𝑜 =

𝑀𝑚𝑜𝑢𝑠𝑒 𝑝ℎ𝑎𝑛𝑡𝑜𝑚
𝑀𝑤𝑎𝑡𝑒𝑟 𝑡𝑎𝑛𝑘

.

The dose rate in the mouse phantom was calculated by multiplying the dose rate at
1 cm in the water phantom by the backscatter ratio, represented by Equation 13:
Equation 13: 𝐷𝑚𝑜𝑢𝑠𝑒 𝑝ℎ𝑎𝑛𝑡𝑜𝑚 = 𝐷1𝑐𝑚 ∗ 𝐵𝑟𝑎𝑡𝑖𝑜
Once the dose rate in the mouse phantom was determined, the irradiation
time needed to deliver a known dose of 300 cGy to the TLD was determined. It
should be noted that the set time was the real time plus the measured end-effect.
Once the time was set, the mouse phantom loaded with TLD was irradiated on top of
the irradiation stand with 80 cm SSD to the top of the mouse phantom. Six
irradiations were performed, unloading and loading the TLD between irradiations.
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On the same date (March 28, 2018) as the mouse phantom irradiations in Co60, irradiations in the X-RAD 225Cx were performed. Ion chamber measurements
were taken to determine the dose rate in the mouse phantom. Then, a known dose
was delivered to the TLD in the mouse phantom in the small animal irradiator. Six
irradiations were performed.
The TLD irradiated in Co-60 and the TLD irradiated in the small animal
irradiator were read in the same session. The energy correction factor for Method 2
was calculated for each irradiation using the following equation:
Equation 14: 𝑘𝑄 =

𝐷
( 𝑚𝑜𝑢𝑠𝑒 ⁄𝑀
)
𝑐𝑜𝑟𝑟 ∗𝑘𝐹 ∗𝑘𝐿 ) 𝑋𝑅𝐴𝐷
𝐷𝑚𝑜𝑢𝑠𝑒
(
)
⁄𝑀
𝑐𝑜𝑟𝑟 ∗𝑘𝐹 ∗𝑘𝐿 ) 𝐶𝑜−60

where Dmouse is the measured dose to muscle to the mouse phantom in cGy/min.
Therefore, the energy correction factor is the ratio of the dose per corrected TLD
signal for 225 kVp compared to reference Co-60.

Results
The average TLD energy correction factor for each irradiation date is plotted
in Figure 20. The error bars represent the standard deviation between irradiations
for a given date. The average TLD energy correction factors derived from Methods
1 and 2 were 0.792  0.006 and 0.791  0.006, respectively. An unpaired t-test
yielded a two-tailed P value of 0.8783, indicating that there is no statistically
significant difference between the results from Methods 1 and 2. Therefore, the
average energy correction factor of 0.792 can be used to verify dose delivered by
users of the service.

46

0.85
Method 1

kQ

Method 2

0.8

0.75
2/1/18

3/3/18
4/2/18
Measurement Date

5/2/18

Figure 20. Comparison of Methods 1 and 2 for determining the energy correction
factor for thermoluminescent dosimeters in the mouse phantom

Statistical Analysis/Uncertainty in the Developed Independent Peer Review System
Methods
An uncertainty analysis in the TLD mail audit service was conducted
according to the methodology presented in Kirby 1992 (Kirby, T.H., Hanson, W.F.,
Johnston, 1992). This methodology computes the uncertainty in the determination
of dose using TLD by means of the TLD dose formula. It combines uncertainties in
measured TL signal, the system calibration factor, and each k-correction factor,
assuming that each is independent and normally distributed. The total uncertainty is
then determined by the quadrature sum of the individual uncertainties, as

47

represented in the equation below (Equation 4, Kirby 1992), and where a prime (‘) is
used to represent factors relating to TLD standards,
𝜕𝐷 2

𝜕𝐷 2

𝜕𝐷

2

𝜕𝐷 2

Equation 15: 𝑠𝐷2 = (𝑠𝑀 𝜕𝑀) + (𝑠𝐷′ 𝜕𝐷′) + (𝑠𝑘𝑄 𝜕𝑘 ) + (𝑠𝑀′ 𝜕𝑀′) +
𝑄

2

(𝑠

𝑘
( 𝐹)
𝑘 ′
𝐹

𝜕𝐷

) + (𝑠

𝑘
𝜕( 𝐹 )
𝑘 ′
𝐹

2
𝜕𝐷
𝑘
( 𝐿)
𝑘 ′
𝐿

) .

𝑘
𝜕( 𝐿 )
𝑘 ′
𝐿

The uncertainty in the TLD energy correction factor, kQ, was calculated by
combining our measurement uncertainty in the calculated value of kQ and the
uncertainty in the measured ion chamber dose reported in TG-61 (Ma, 2001, Table
III). All other uncertainties in the TLD dose factors were taken directly from the work
of AAPM Task Group 91 (Kry et al., n.d., Table 6.2) . The total uncertainty in the
developed peer review service was then calculated using equation 15.

Results
The uncertainty in the developed mail audit service was determined (Table 4).
The resulting analysis indicated that the developed independent peer review service
has a 1-sigma uncertainty of 4.2%. However, this uncertainty is only applicable if
the HVL has been appropriately measured under narrow-beam geometry. The TLD
energy correction factor varies greatly with HVL in the orthovoltage energy range
(Kry et al., n.d.).
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Uncertainty (%)

Variable
D0

0.6

M0

0.7

Mraw

1.7

kL

0.1

kF

0.7

k

0.0

kQ

3.7

Total (1-sigma)

4.2

Total (2-sigma)

8.5

Table 4. Uncertainty budget for the developed independent peer review system for
the X-RAD 225Cx
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Chapter 4: Conducting a Pilot Study
Measurements on another X-RAD 225Cx unit
Methods
In order to determine the variability in X-RAD 225Cx units and assess the
feasibility of the independent peer review system, we collaborated with an X-RAD
225Cx user at another academic institution; hereafter, referred to as Institution A (for
anonymity).
We were interested in comparing the beam output and mouse dosimetry
measured in our irradiator to that of Institution A’s irradiator. First, the narrow-beam
HVL was determined and TG-61 output measurements were taken (following the
previously described methods). Second, once the beam output was determined, ion
chamber measurements in the mouse phantom were acquired to determine absolute
dosimetry in the mouse phantom. Although MD Anderson and Institution A have
identical irradiator models, the interior dimensions of the unit were not the same.
The distance from the metal platform at the bottom of the irradiator to the isocenter
is shorter by a couple centimeters in Institution A’s irradiator. Therefore, the TAR
experimental setup differed from that used at our unit because the irradiation stand
was too tall to place the mouse phantom at the isocenter. The setup was modified
by placing the mouse phantom on the animal platform and adjusting the stage to
place the ion chamber at isocenter (Figure 21).
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Figure 21. Experimental setup for pseudo tissue air ratio measurements in the
mouse phantom at Institution A
Once the dosimetry in the mouse phantom was characterized with ion
chamber measurements, TLD were irradiated to a known dose in the TLD mouse
phantom according to Method 1 above in order to characterize the TLD energy
correction factor. The TLD in the phantom were centered to the isocenter of the unit
using the adjustable animal stage.
Results
Although the two animal irradiators are the same model, their beam qualities
differed. This is likely the result of slight differences in the x-ray tube and filtration of
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each unit. The measured beam quality of Institution A’s irradiator was higher than
that of our irradiator. The narrow-beam HVL of Institution A was 0.966 mm Cu and
11.49 mm Al; 12.9% and 5.4% (respectively) higher than our institution’s HVL. The
TG-61 output (absorbed dose to the surface of a water phantom) of Institution A was
370.0 cGy/min; 13.1% lower than our institution’s average output. The pseudo TAR
was 1.068, which is within the measurement range for our unit. As expected from
the lower TG-61 output, the dose rate in the mouse was 13.5% lower, measuring
294.8 cGy/min to muscle.
Because the energy dependence of the ion chamber is negligible, there is no
need for an ion chamber energy correction factor. This not the case for TLD
dosimetry, where the sensitivity is dependent on the energy and particularly so in the
orthovoltage energy range. The energy correction factor of the TLD in the mouse
phantom was determined using Method 1. The average energy correction factor for
Institution A was 0.811  0.003. This energy correction factor is 2.4% higher than
that of our institution (Figure 22). The higher correction factor means that the
overresponse of TLD is lesser for Institution A; this is to be expected for higher beam
qualities. Less of a correction is needed the closer the energy is to reference Co-60.
The results of the feasibility measurements indicate the importance of properly
characterizing the narrow-beam HVL for accurate TLD dosimetry.
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Figure 22. Comparison of thermoluminescent dosimeter energy correction factors
determined for X-RAD 225Cx animal irradiators at MD Anderson and Institution A

Mail Audit Feasibility Study
Methods
In order to test the feasibility of the developed mail audit service, we
conducted two test audits carried out at two different institutions. To each institution,
we sent the mouse phantom, irradiation stand, an irradiation data form (Figure 23),
and irradiation instructions (Figure 24). They were asked to deliver 300 cGy to the
center of the mouse phantom.
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MONITORING OUTPUT OF AN ORTHOVLTAGE X-RAY
BEAM FOR A SMALL ANIMAL IRRADIATOR
Institution: #

-

Date Mailed:

Date of Irradiation:

Person(s) Irradiating dosimeters:
Primary Physicist:
Physicist Email:

Phone Number:

Radiation Machine (manufacturer/model):

Serial Number:

kVp:

HVL:

Mouse Phantom Irradiation Conditions

Field size:

cm2

x

Timer setting:

sec

Timer/end error:

sec

Dose delivered:

cGy

OR

cm diameter circle

muscle
soft tissue
water

Backscatter factor:

Figure 23. Irradiation data form used for independent peer review feasibility studies
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SMALL ANIMAL IRRADIATOR INDEPENDENT PEER REVIEW INSTRUCTIONS
INSTRUCTIONS FOR IRRADIATING TLD IN MOUSE PHANTOM
1. Assemble the irradiation stand as follows. Unfold the four legs into the shape
of a rectangle and secure with a piece of tape. Place the platform top on the
legs. The assembled stand is shown in the Figure 1.

Figure 1- Assembled irradiation stand
and platform for mouse phantom
irradiation
2. Place the assembled stand on the metal surface at the bottom of the
irradiator. Place the mouse phantom loaded with TLD on top of the irradiation
platform. Raise the height of the stand by adding paper underneath.
Continue adding paper until the TLD are at the unit isocenter height, indicated
by alignment of the horizontal side crosshair on the mouse with the horizontal
laser (Figure 2). Once the height is correct, align the mouse phantom in all
three dimensions. All crosshairs should coincide with the unit lasers (Figure
3).

Figure 2- proper stand height
has been reached, indicated
by alignment of horizontal
cross-hair with laser

Figure 3- mouse phantom
crosshairs aligned with
irradiator lasers
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3. Place the treatment filter and the 10 cm x 10 cm cone in the accessory tray.
The complete irradiation setup is shown in Figure 4.

Figure 4- Setup for Mouse Phantom
Irradiation
4. Set the irradiator to 225 kVp and 13 mA. Determine the irradiation time
needed to deliver 300 cGy at 1 cm depth to the center of the mouse at the
isocenter for a 10 cm x 10 cm field size. Irradiate the phantom.
5. Complete the TLD datasheet. Fill in all requested information, as incomplete
forms will delay the processing of your TLD. Please send back the TLD via
regular U.S. mail using the address label provided. TLD cannot be read until
7 days after irradiation. If you wish to return TLD by an express or direct
carrier, use the following address: Radiation Dosimetry Services, 8060
El Rio Street, Houston, TX 77054. If you have any questions, please call
Radiation Dosimetry Services (RDS) at (713) 745-8999 or you may e-mail us
at RDS@mdanderson.org.

Figure 24. Instruction form used for independent peer review for feasibility studies
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Results
Mail Audit Results for Institution A
We selected institution A as one of the mail audit participants, since we had
fully characterized their TLD dosimetry. The physicist responsible for the irradiator
performed the mail audit. He specified that he delivered 300 cGy to water to the
mouse with a backscatter factor of 1.35. The TLD were later read by RDS. Using
our measured energy correction factor for institution A of 0.811, the calculated TLD
dose was 224.9 cGy to water. The TLD dose was 25% lower than Institution A’s
specified dose of 300 cGy.
After follow-up with Institution A, we identified that they had treated the peer
review output check as a TG-61 calibration check, rather than a mouse dosimetry
check. Their irradiation time was selected based on the dose rate to the surface of a
full water phantom, rather than the dose rate at 1 cm depth in a mouse. We
converted Institution A’s specified dose to the dose to the mouse phantom by
accounting for the incorrect backscatter factor using Equation 16:
Equation 16: 𝐷𝑚𝑜𝑢𝑠𝑒 =

𝐷𝑓𝑢𝑙𝑙 𝑝ℎ𝑎𝑛𝑡𝑜𝑚
𝐵𝐴

∗ 𝑇𝐴𝑅

where Dfull phantom is Institution A’s specified dose of 300 cGy to water, B A is institution
A’s specified backscatter factor of 1.35, and TAR is our measured backscatter in the
mouse. Dmouse was calculated to be 238.9 cGy to water. Using an institution
specified dose of 238.9 cGy, the calculated TLD dose was 229.6 cGy to water (using
linearity correction factor based on Dmouse). The calculated TLD dose was 3.9%
lower than Dmouse.
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While this mail audit feasibility test demonstrated that Institution A has a
properly calibrated unit, it did not answer the important question regarding whether
the institution could deliver a specified dose to a mouse (or mouse phantom). Thus,
we again followed-up with the physicist at Institution A and asked how he would
determine the time needed to deliver 300 cGy to a mouse. He responded that an inhouse Monte Carlo treatment planning software is used. Based on this feedback,
we determined that a more appropriate test of small animal dosimetry would be an
end-to-end test. For this type of test, we would instruct the user to image, treatment
plan, and irradiate the phantom on the animal stage as they would a real mouse.
Mail Audit Results for Institution B
The mail audit was tested at a second institution, hereafter referred to as
Institution B. A technician performed the irradiation at Institution B, rather than a
medical physicist. Because some small animal irradiator users do not have
physicists involved in the dosimetry, it is important that our audit procedures are
easy to follow for both types of users. Based on the feedback from the mail audit
with Institution A, we decided to have Institution B irradiate the mouse phantom as
they would a real mouse, rather than following the original procedure (Figure 24).
The institution imaged the phantom with on-board CBCT, developed a single-beam
treatment plan to deliver 300 cGy to water at the location of the TLD capsules, and
delivered the treatment. The TLD were later read by RDS, and it was determined
that the TLD received a dose of 367.7 cGy to water, 22.6% higher than the specified
dose. After contacting the institution and investigating the dosimetric discrepancy, it
was determined that the dose rate that was used to irradiate the phantom was for an

58

incorrect field size, 10 mm x 10 mm rather than 10 cm x 10 cm. The institution was
asked to repeat the mail audit. The TLD measured dose from the repeat mail audit
was 309.7 cGy to water, 3.2% higher than the specified dose.
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Chapter 5: Conclusions
General Review
We hypothesized that an independent peer review system for a small animal
irradiator could be developed that has an uncertainty of less than ±10%.
Specifically, that a mail audit service could be created with an action criterion of
±10%, meaning that mail audit users would be contacted by RDS technical staff if
TLD discrepancies were outside of this criterion and a repeat irradiation would be
suggested. This hypothesis was reasonable and perhaps overly permissive given
that the experimental uncertainties in TLD dose measured using the RDS protocol
are less than 1.5% (Kirby, T.H., Hanson, W.F., Johnston, 1992).
Our mail audit results indicated that two institutions were able to deliver a
specified dose to the mouse phantom within ±5%, which is consistent with the 1sigma uncertainty of 4.2% in the developed independent peer review service.
However, it is important to note that the narrow-beam HVL was properly
characterized by a physicist (with good narrow beam geometry) at both mail audit
institutions. The TLD energy correction factor varies greatly with HVL in the
orthovoltage energy range (Kry et al., n.d.). A comparison of measurements at MD
Anderson and Institution A indicate that a difference in HVL as small as 0.1 mm Cu
can result in a 2.5% difference in TLD energy correction factor. These differences
can only be accounted for if the HVL is determined under narrow-beam geometry.
However, many institutions do not measure HVL under narrow-beam geometry. In
fact, many users do not measure HVL at all, but rather rely on manufacturer
specifications (Seed et al., 2016). Therefore, while the output checks for the two
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institutions evaluated in our feasibility study were within 5%, given the additional
uncertainty in the HVL data from different institutions, a mail audit criterion of ±10%
for the X-RAD 225Cx irradiator is more appropriate. Based on the measured
variation in kQ with HVL, a 1-sigma uncertainty of 10% is appropriate for beam
qualities between 0.65 – 1.15 mm Cu HVL.

Future Work
The feasibility studies highlighted the importance of both beam output and
end-to-end testing services for independent peer review. Moving forward, RDS will
offer peer review services for both in-air output checks (preliminary results, Appendix
B) and mouse phantom end-to-end dosimetric verification.
While TLD energy correction factors have been characterized versus HVL for
clinical orthovoltage irradiators, further characterization is needed for cabinet
irradiators. The narrow-beam HVL and TLD dosimetry both in-air and in-mouse
phantom should be characterized for other X-RAD 225Cx irradiators in use.
This thesis work determined the TLD energy correction factor in the mouse
phantom for a 10 cm x 10 cm field size. Future studies should be conducted to
determine the variation of the TLD energy correction factor for different field sizes.
While a 10 cm x 10 cm field size may be used for mouse total body irradiation,
radiobiology studies typically use smaller field sizes to target localized regions of
disease. Characterizing the TLD energy correction factor would allow researchers to
test the dosimetry for their specific irradiation protocols.
Lastly, the methodology presented in this work should be expanded to other
small animal irradiator models so RDS can provide more comprehensive service.
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Given the apparent need for dosimetric standardization in small animal dosimetry
and the lack of physics involvement, expanding the independent peer review service
to include on-site visits for institutions with large dosimetric discrepancies will also be
investigated.
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Appendices
Appendix A: Effect of half-value layer geometry on TG-61 output
Methods
TG-61 requires accurate measurement of HVL under narrow-beam geometry.
An in-house narrow-beam collimation device with a removable Cerrobend collimator
(R Tailor) was used to determine the effect of narrow-beam collimation on TG-61
output. HVL measurements were taken with (Figure A-1a) and without (Figure A-1b)
the narrow-beam collimator. The TG-61 in-air method was conducted to determine
the effect of narrow-beam collimation on beam output.

(a)

(b)

Figure A-1. (a) Experimental setup for measuring half-value layer under narrowbeam geometry, and (b) experimental setup for measuring half-value layer under
good geometry
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Results
The narrow-beam collimated HVL was determined to be 0.86 mm Cu and
10.82 mm Al. The half-value layer under good geometry, without narrow-beam
collimation, was determined to be 0.91 mm Cu and 12.97 mm Al. The 6%-20%
increase in half-value layer when the narrow-beam collimator is not used can be
attributed to an increase in scattered dose reaching the ion chamber. The TG-61
“in-air” method was used to determine absorbed dose to water at the surface of a
water phantom for each half-value layer result. An absorbed dose to water rate of
436.1 cGy/min and 435.5 cGy/min was determined for the narrow-beam geometry
and good geometry, respectively. These results are shown in Table A-1.

Copper HVL (mm Cu)

With narrow-beam
collimation
0.86

Without narrow-beam
collimation
0.91

Aluminum (HVL)

10.82

12.97

TG-61 Output (cGy/min)

436.1

435.5

Table A-1. Impact of narrow-beam collimation on Task Group 61 output
Using our narrow-beam collimation device resulted in the most accurate dose
rate calculation for the X-RAD 225Cx small animal irradiator. However, using good
geometry without narrow-beam collimation proved to have a minimal impact (0.14%)
on the resulting calibrated output. Therefore, it can be concluded that making a
narrow-beam collimation device for HVL measurements of small animal irradiators is
not necessary for proper ion chamber dosimetry. However, properly characterizing
the HVL according to narrow-beam geometry is important for TLD dosimetry, as
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there is a steep response between HVL and the TLD energy correction factor at
orthovoltage energies.
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Appendix B: Beam Output Check for small animal irradiators with In-Air TLD
Determining In-Air TLD Energy Correction Factor for X-RAD 225Cx
Methods
RDS offers independent peer review of beam output for orthovoltage beams
(typically for clinical units) with a passing criterion of  10%. The RDS has
characterized the TLD energy correction factor in-air versus HVL measured in mm
Cu (Figure B-1). The HVL expressed in copper was converted to aluminum using
BJR 25 published data (Aird et al., 1996) (Figure B-2). The RDS has monitored
beam output of the X-RAD 225Cx and X-RAD 320 small animal irradiators for three
institutions over the last decade for HVL ranging from 0.9-1.035 mm Cu and 2.63-3.1
mm Al. A total of 20 mail audits between the three institutions has been performed.
Every mail audit has passed the  10% criterion. The average ratio of TLD
measured dose to institution stated dose was 0.979  0.027. The average absolute
percent difference was 2.8  1.8%.
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Figure B-1. Plot of RDS data for thermoluminescent dosimeter energy correction
factor versus half-value layer measured with copper attenuating sheets
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Figure B-2. Plot of RDS data for thermoluminescent dosimeter energy correction
factor versus half-value layer expressed in millimeters of aluminum

The TLD energy correction factor in-air in our X-RAD 225Cx unit and
Institution A’s unit was determined according to Method 1 presented in Chapter 3.
TG-61 output measurements were converted to dose in free space to muscle.
Measurements were taken with the A1SL chamber free in-air at the isocenter for a
10 cm x 10 cm field size, 225 kVp tube potential, and 13 mA tube current. Once the
dose rate was determined with ion chamber measurements, TLD were suspended
in-air from the irradiation stand using tape, aligned to the isocenter, and irradiated to
a known dose (Figure B-3). The TLD were read, and the measured TLD dose was
compared to the ion chamber dose to determine the TLD energy correction factor
(Method 1).
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Figure B-3. Experimental setup for irradiating thermoluminescent dosimeters in-air
Results
At MD Anderson, ion chamber measurements and TLD irradiations in-air
were performed on five dates to characterize the TLD energy correction factor. The
average dose rate in free space to muscle measuring with the ion chamber was
317.6  3.2 cGy/min. The TLD energy correction factor was 0.797  0.016. This is
less than 1% different from the TLD energy correction factor in-mouse.
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Institution A’s TLD energy correction factor in-air was 0.831  0.008. This is 2.5%
different from Institution A’s correction factor in-mouse. The in-air TLD energy
correction factor data is shown in Figure B-4.
The TLD Energy correction factors for MD Anderson and Institution A were
compared to the values RDS uses for orthovoltage beam output. Based on Figure
B-1, MD Anderson’s TLD energy correction factor should be 0.754 and Institution A’s
should be 0.764. Therefore, using the RDS orthovoltage energy correction factor
data for the X-RAD 225Cx for MD Anderson and Institution A would result in
measured TLD errors of 5.4% and 8.0% respectively. These differences are likely
due to the differences in scatter environment of cabinet irradiators compared to
clinical orthovoltage irradiators. This result highlights the need to characterize the
TLD energy correction factor versus HVL for small animal irradiators.
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Figure B-4. Thermoluminescent dosimeter energy correction factors in-air
Mail Audit Beam Output Checks for X-RAD 225Cx
Methods
Along with the in-mouse mail audit, Institutions A and B were asked to
performing beam output checks with TLD suspended in-air. Figure B-5 contains the
irradiation instructions for the output check. The institutions were asked to deliver
300 cGy in-air at their isocenter.
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MONITORING OUTPUT OF ORTHOVOLTAGE BEAM FROM SMALL ANIMAL
IRRADIATOR
INSTRUCTIONS FOR IRRADIATING TLD IN-AIR
1. Take the stand and the mouse phantom out of the irradiator. Remove the top
platform on the irradiation stand, leaving just the legs of the stand. Place a
long piece of tape across the top, as shown in Figure 1 below. Make sure
the tape is snug and doesn’t sag.

Figure 1- Secure piece of tape
across the irradiation stand
2. Stick the three TLD capsules (colored plugs aligned in the same orientation)
on a piece of tape and secure to the tape on the stand, as shown in Figure 2
below.
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Figure 2- TLD capsules
secured to irradiation stand.
3. Place the stand inside the irradiator on the paper. Remove the 10 cm x 10
cm cone. Add more paper until the center of the TLD powder is aligned to the
horizontal laser. Once you have reached the correct height, move the stand
until the center of the TLD powder is at the isocenter, indicated by alignment
with all of the lasers, shown in Figure 3 below.

Figure 3- Aligning the TLD
powder to the unit isocenter
4. Insert the 10 cm by 10 cm cone. The irradiation setup is shown in Figure 4
below. Set the irradiation time to deliver a dose in free space of 300 cGy at
the location of the TLD.

73

Figure 4- Setup for in-air TLD
irradiation
5. Complete the TLD datasheet. Fill in all requested information, as incomplete
forms will delay the processing of your TLD. Please send back the TLD via
regular U.S. mail using the address label provided. TLD cannot be read until
7 days after irradiation.
If you wish to return TLD by an express or direct carrier, use the
following address: Radiation Dosimetry Services, 8060 El Rio Street,
Houston, TX 77054.
If you have any questions, please call Radiation Dosimetry Services (RDS) at
(713) 745-8999 or you may e-mail us at RDS@mdanderson.org.

Figure B-5. Beam Output Check Instructions
Results
Both Institutions A and B stated that the TLD received 300 cGy to water. The
TLD measured dose for Institution A was 305.2 cGy to water; the ratio of measured
dose to institution stated dose was 1.02. The TLD measured dose for Institution B
was 299.5 cGy to water; the ratio of measured dose to institution stated dose was
0.99. Both institutions passed the beam output check well within the 10% criterion.
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